Has Charles Getz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,089,632 in general payments to Charles Getz, MD across 322 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charles Getz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charles Getz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charles Getz, MD

Orthopaedic Surgery · Glen Mills, PANPI 1063440527

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $892,594 of the $1,089,632 with a category attached, or 81.9%. Zimmer Biomet accounts for 99.9% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $355,085, more than ten times the $33,003 reported in 2019. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,089,632in general payments, 2019–2025

Across 322 payments — averaging $3383.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$1.1M
Stryker$181
Catalyst Orthoscience$168
Exactech, Inc.$156
Davol Inc.$145
Medtronic$66
plus $266 from 9 others

$30,711in research payments, 2019–2025

Across 7 payments — averaging $4387.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Zimmer Biomet$31K

What the payments were for

Royalty or licence$892,59482%
Consulting fees$105,65010%
Travel & lodging$19,2192%
Food & beverage$5,2740%
Education$66,8956%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	298	$1,088,651
Stryker	2	$181
Catalyst Orthoscience	1	$168
Exactech, Inc.	2	$156
Davol Inc.	7	$145
Medtronic	2	$66
Johnson & Johnson	1	$60
Orthofix Medical, Inc.	1	$39
Smith+Nephew	1	$39
Paladin Technology Solutions	2	$37
Dynasplint Systems Inc.	1	$25
ERMI LLC	1	$21
Vertex	1	$17
Amgen	1	$16
Acumed LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Identity$784,041
Comprehensive Shoulder System$85,981
Biowick$47,945
BioWick X$34,812
Comprehensive Reverse$32,500
Anatomical Shoulder Bigliani/Flatow$30,671
ALLIANCE$23,625
Comprehensive Anatomic$21,500
Signature Glenoid Guides$11,000
Persona$2,439
Juggerknotless Soft Anchor$1,750
Comprehensive Primary Stem$1,550
PD-Extremities-New Product$1,462
Catalyst Total CSR$168
AXSOS$153
Avenir$125
EQUINOXE$109
Connected Health-None$106

How this compares

$1,089,632 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$305,367

Medicare patients

601

Services billed

4,166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	69	$425
Methylprednisolone	73	$415
Tramadol Hcl	24	$90
Oxycodone Hcl	19	$68
Amoxicillin	14	$33
Meloxicam	11	$29

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Glen Mills

William HozackBensalem$10.6M
Jess LonnerBryn Mawr$7.8M
Gerald WilliamsBryn Mawr$6.8M
Mark LazarusBensalem$6.4M
John FenlinPhiladelphia$5.9M
Peter SharkeyKing Of Prussia$5.7M
Alexander VaccaroPhiladelphia$4.5M
Selene ParekhBensalem$4.5M
Joseph AbboudPhiladelphia$3.9M
Jonathan GarinoMalvern$3.8M

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →